In T1D, IL-23 exacerbates pancreatic inflammation and accelerates β-cell destruction by enhancing the production of cytokines such as IL-17, IFN-γ, TNF-α, and IL-18. This evidence concerns the gene IL17A and type 1 diabetes mellitus.